美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=LAMIVUDINE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE 022537 001 NDA LAMIVUDINE, NEVIRAPINE, AND STAVUDINE TABLET; ORAL 150MG;200MG;30MG No No 2010/08/30 (TA) -- MACLEODS PHARMA None (Tentative Approval)
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE 200244 001 NDA LAMIVUDINE; NEVIRAPINE; STAVUDINE TABLET; ORAL 150MG; 200MG; 30MG No No 2010/09/10 (TA) -- HETERO DRUGS LTD None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE 200748 001 NDA LAMIVUDINE; ZIDOVUDINE TABLET; ORAL 30MG; 60MG No No 2011/01/05 (TA) -- MATRIX LABS LTD None (Tentative Approval)
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE 200623 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET; ORAL 300MG; 300MG No No 2011/03/04 (TA) -- CIPLA LIMITED None (Tentative Approval)
LAMIVUDINE 078636 001 ANDA LAMIVUDINE TABLET; ORAL 150MG No No 2011/03/22 (TA) -- TEVA PHARMS None (Tentative Approval)
LAMIVUDINE 078636 002 ANDA LAMIVUDINE TABLET; ORAL 300MG No No 2011/03/22 (TA) -- TEVA PHARMS None (Tentative Approval)
ABACAVIR SULFATE; LAMIVUDINE 202007 001 NDA ABACAVIR SULFATE; LAMIVUDINE TABLET, FOR SUSPENSION; ORAL 60MG; 30MG No No 2011/05/12 (TA) -- CIPLA LIMITED None (Tentative Approval)
LAMIVUDINE AND ZIDOVUDINE 079081 001 ANDA LAMIVUDINE; ZIDOVUDINE TABLET;ORAL 150MG;300MG No No 2011/05/25 2011/05/25 CHARTWELL RX Discontinued
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE 202171 001 NDA LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE; NEVIRAPINE TABLET; ORAL 300MG; 300MG; 200MG No No 2011/09/08 (TA) -- MATRIX LABS LTD None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE 201151 001 NDA LAMIVUDINE; ZIDOVUDINE TABLET; ORAL 30MG; 60MG No No 2011/09/22 (TA) -- CIPLA LIMITED None (Tentative Approval)
LAMIVUDINE 202032 001 ANDA LAMIVUDINE TABLET;ORAL 150MG No No 2011/11/17 2011/11/17 AUROBINDO PHARMA LTD Discontinued
LAMIVUDINE 202032 002 ANDA LAMIVUDINE TABLET;ORAL 300MG No No 2011/11/17 2011/11/17 AUROBINDO PHARMA LTD Discontinued
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE 202157 001 NDA LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET; ORAL 150MG; 200MG; 300MG No No 2011/11/18 (TA) -- HETERO LABS UNIT III None (Tentative Approval)
LAMIVUDINE 091606 001 ANDA LAMIVUDINE TABLET;ORAL 150MG No No 2011/12/02 2011/12/02 APOTEX Prescription
LAMIVUDINE 091606 002 ANDA LAMIVUDINE TABLET;ORAL 300MG No No 2011/12/02 2011/12/02 APOTEX Prescription
ABACAVIR SULFATE; LAMIVUDINE 202381 001 NDA ABACAVIR SULFATE; LAMIVUDINE TABLET; ORAL 60MG; 30MG No No 2012/01/31 (TA) -- MYLAN LABS None (Tentative Approval)
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE 202589 001 NDA LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE TABLET; ORAL 150MG; 200MG; 300MG No No 2012/02/08 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
LAMIVUDINE AND ZIDOVUDINE 090246 001 ANDA LAMIVUDINE; ZIDOVUDINE TABLET;ORAL 150MG;300MG No No 2012/05/15 2012/05/15 LUPIN LTD Prescription
LAMIVUDINE AND ZIDOVUDINE 202418 001 ANDA LAMIVUDINE; ZIDOVUDINE TABLET;ORAL 150MG;300MG No No 2012/05/15 2012/05/15 AUROBINDO PHARMA LTD Discontinued
LAMIVUDINE 200406 001 ANDA LAMIVUDINE TABLET; ORAL 150MG No No 2012/05/30 (TA) -- MICRO LABS LTD None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database